Ricardo Alonso 4
4 · Ra Pharmaceuticals, Inc. · Filed Jun 25, 2019
Insider Transaction Report
Form 4
Ricardo Alonso
See Remarks
Transactions
- Sale
COMMON STOCK
2019-06-21$23.72/sh−2,857$67,782→ 11,428 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2019.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.385 to $24.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.